Contribution: Industrial Research Assistance Program – Contributions to Firms
Phagelux ( Canada ) Inc.
$300,000.00
Biologics for the treatment of wound infections
FY 2018-19 · 2018-04-02
Summary
Phagelux (Canada) Inc. is developing unique delivery technologies of novel biologics to tackle multi-drug resistant infections in wounds. The goal of the project is to scale-up the production of the various components of the delivery system in an effort to comply to regulatory requirements for pre-clinical and Phase I clinical studies.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mono|Mono, Quebec, Canada
Recipient Type
For-profit organization
Business Number
807691589
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-04-02 | 2018-19 | $300,000.00 |
| 1 | 2018-04-02 | 2018-19 | $300,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 63 days.
Additional Information (French)
La date de fin du présent accord a été changé de 63 jours. Cet accord a été modifié 1 fois
Agreement End Date
2019-08-30
Agreement Number
905608
Agreement Start Date
2018-04-02
Agreement Title
Biologics for the treatment of wound infections
Agreement Title (French)
Produits biologiques pour le traitement des infections de plaie
Agreement Type
Contribution
Agreement Value
$300,000.00
Amendment Date
2019-06-20
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Phagelux (Canada) Inc. is developing unique delivery technologies of novel biologics to tackle multi-drug resistant infections in wounds. The goal of the project is to scale-up the production of the various components of the delivery system in an effort to comply to regulatory requirements for pre-clinical and Phase I clinical studies.
Description (French)
Phagelux (Canada) Inc. est en train de développer des technologies de prestation unique de nouveaux produits biologiques pour guérir les infections de plaie à polypharmacorésistant. Le but du projet est de mettre à l'échelle la production de divers éléments du système de prestation dans un effort de se conformer aux exigences réglementaires pour les études précliniques et cliniques Phase I.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mount Royal
Federal Riding (French)
Mont-Royal
Federal Riding Number
24052
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
807691589
Recipient City
Mono|Mono
Recipient Country
CA
Recipient Legal Name
Phagelux ( Canada ) Inc.
Recipient Postal Code
H4P 2R2
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2018-2019-Q1-905608
